BioPharma Credit (BPCR) Stock Chart & Stock Price History GBX 0.87 +0.00 (+0.23%) As of 08/1/2025 12:31 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesBuy This Stock BioPharma Credit Stock Price Performance The BioPharma Credit (BPCR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 4.40%, with a year-to-date return of -1.58%. In the past month, the stock has decreased 1.14%, reflecting recent market activity. As of the latest close, BioPharma Credit traded at GBX 0.87 with a market cap of £1.03 billion and volume of 594,452 shares. Five years ago, the stock traded at GBX 1, representing a 12.65% decrease over that period. At the time, it had a market cap of £13.68 million and a volume of 288,063 shares. Receive BPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.46%1 Month Performance-1.14%3 Month Performance+1.16%Year-To-Date Performance-1.58%1 Year Performance-4.40%5 Year Performance-12.65% BPCR Stock Chart for Saturday, August, 2, 2025 BPCR Chart by TradingView BioPharma Credit Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025GBX 0.87GBX 0.87+0.23%GBX 0.87GBX 0.86594,452 shs£1.03 billion07/31/2025GBX 0.87GBX 0.87-0.69%GBX 0.88GBX 0.871.17 million shs£1.03 billion07/30/2025GBX 0.87GBX 0.87+0.46%GBX 0.88GBX 0.86895,644 shs£1.04 billion07/29/2025GBX 0.87GBX 0.87-0.46%GBX 0.88GBX 0.871.08 million shs£1.03 billion07/28/2025GBX 0.87GBX 0.87+0.46%GBX 0.88GBX 0.87340,206 shs£1.04 billion07/25/2025GBX 0.87GBX 0.87-0.46%GBX 0.88GBX 0.871.41 million shs£1.03 billion07/24/2025GBX 0.88GBX 0.87-0.23%GBX 0.88GBX 0.871.86 million shs£1.04 billion07/23/2025GBX 0.88GBX 0.88-0.23%GBX 0.88GBX 0.88400,682 shs£1.04 billion07/22/2025GBX 0.88GBX 0.88-0.23%GBX 0.89GBX 0.88565,088 shs£1.04 billion07/21/2025GBX 0.88GBX 0.88-0.23%GBX 0.89GBX 0.88747,994 shs£1.04 billion Get the Latest News and Ratings for BPCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025GBX 0.88GBX 0.88GBX 0.89GBX 0.88693,544 shs£1.05 billion07/17/2025GBX 0.88GBX 0.88GBX 0.89GBX 0.88263,028 shs£1.05 billion07/16/2025GBX 0.88GBX 0.88+0.23%GBX 0.88GBX 0.88284,453 shs£1.05 billion07/15/2025GBX 0.88GBX 0.88GBX 0.89GBX 0.87315,389 shs£1.04 billion07/14/2025GBX 0.87GBX 0.88+0.69%GBX 0.88GBX 0.871.61 million shs£1.04 billion07/11/2025GBX 0.88GBX 0.87-0.91%GBX 0.89GBX 0.861.78 million shs£1.04 billion07/10/2025GBX 0.88GBX 0.88+0.23%GBX 0.89GBX 0.871.52 million shs£1.05 billion07/09/2025GBX 0.88GBX 0.88GBX 0.88GBX 0.88689,551 shs£1.04 billion07/08/2025GBX 0.88GBX 0.88-0.45%GBX 0.89GBX 0.88251,697 shs£1.04 billion07/07/2025GBX 0.88GBX 0.88+0.45%GBX 0.89GBX 0.88568,603 shs£1.05 billion07/04/2025GBX 0.88GBX 0.88GBX 0.89GBX 0.88689,071 shs£1.04 billion07/03/2025GBX 0.88GBX 0.88-0.23%GBX 0.89GBX 0.88689,071 shs£1.04 billion07/02/2025GBX 0.88GBX 0.88-0.45%GBX 0.89GBX 0.88943,695 shs£1.04 billion07/01/2025GBX 0.88GBX 0.88GBX 0.89GBX 0.88638,505 shs£1.05 billion Related Companies abrdn Stock Price Chart Petershill Partners Stock Price Chart 3i Infrastructure Stock Price Chart JPMorgan Global Growth & Income Stock Price Chart Burford Capital Stock Price Chart RIT Capital Partners Stock Price Chart Bridgepoint Group Stock Price Chart Man Group Stock Price Chart Monks Stock Price Chart HarbourVest Global Private Equity Stock Price Chart Receive BPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BPCR) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPharma Credit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
